Long‐term all‐cause mortality of metabolic‐dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study DOI

Jaycie Koh,

Ayman Mohamed, Gwyneth Kong

и другие.

Diabetes Obesity and Metabolism, Год журнала: 2024, Номер 27(2), С. 683 - 696

Опубликована: Ноя. 11, 2024

Metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity increases risk of cardiovascular disease. This cohort study examines the prognostic value MASLD, across body weight categories, in a secondary preventative acute myocardial infarction (AMI) cohort.

Язык: Английский

Editorial: The heart of NAFLD DOI Creative Commons
Nicholas Chew, Kannan Shankar, Bryan Chong

и другие.

Frontiers in Medicine, Год журнала: 2023, Номер 10

Опубликована: Май 22, 2023

EDITORIAL article Front. Med., 22 May 2023Sec. Gastroenterology Volume 10 - 2023 | https://doi.org/10.3389/fmed.2023.1209625

Язык: Английский

Процитировано

10
Young-onset chronic kidney disease in Mexico: Secondary analysis of global burden of disease study, 1990–2019 DOI
Claudio Alberto Dávila-Cervantes, Marcela Agudelo‐Botero

Preventive Medicine, Год журнала: 2024, Номер 181, С. 107901 - 107901

Опубликована: Фев. 20, 2024

Язык: Английский

Процитировано

2
Exposure to outdoor artificial light at night increases risk and burden of metabolic disease in Ningxia, China DOI
Huihui Wang,

Xiaohong Ma,

Zhenfan Yu

и другие.

Environmental Science and Pollution Research, Год журнала: 2023, Номер 30(37), С. 87517 - 87526

Опубликована: Июль 10, 2023

Язык: Английский

Процитировано

4
Sex differences in survival following acute coronary syndrome with and without standard modifiable risk factors DOI

Vickram Vijay Anand,

Jaycie Koh,

Tian-Seng Teo

и другие.

Clinical Research in Cardiology, Год журнала: 2024, Номер unknown

Опубликована: Ноя. 12, 2024

Язык: Английский

Процитировано

1
Long‐term all‐cause mortality of metabolic‐dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study DOI

Jaycie Koh,

Ayman Mohamed, Gwyneth Kong

и другие.

Diabetes Obesity and Metabolism, Год журнала: 2024, Номер 27(2), С. 683 - 696

Опубликована: Ноя. 11, 2024

Metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity increases risk of cardiovascular disease. This cohort study examines the prognostic value MASLD, across body weight categories, in a secondary preventative acute myocardial infarction (AMI) cohort.

Язык: Английский

Процитировано

0